Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Neoplasm Antigens. Found 16 abstracts

Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. 2018 Oct 04;175(2):416-428e13.   PMCID: PMC6482006
de Oliveira JF, Lima TS, Vendramini-Costa DB, de Lacerda Pedrosa SC, Lafayette EA, da Silva RM, de Almeida SM, de Moura RO, Ruiz A, de Carvalho JE, de Lima M. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay. European journal of medicinal chemistry. 2017 Aug 18;136:305-14.
Moy RH, Huffman AP, Richman LP, Crisalli L, Wang XK, Hoxie JA, Mick R, Emerson SG, Zhang Y, Vonderheide RH, Porter DL, Reshef R. Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis. Blood. 2017 Feb 16;129(7):906-16.   PMCID: PMC5314813
Adams DL, Stefansson S, Haudenschild C, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch((R)) CTC test. Cytometry A. 2015 Feb;87(2):137-44.
Doss M, Kolb HC, Walsh JC, Mocharla VP, Zhu Z, Haka M, Alpaugh RK, Chen DY, Yu JQ. Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers. Mol Imaging Biol. 2014 Oct;16(5):739-46.
Motzer RJ, Hutson TE, Hudes GR, Figlin RA, Martini JF, English PA, Huang X, Valota O, Williams JA. Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma. Cancer Chemother Pharmacol. 2014 Oct;74(4):739-50.   PMCID: 4175044
Suresh T, Lee LX, Joshi J, Barta SK. New antibody approaches to lymphoma therapy. Journal of hematology & oncology. 2014 Sep;7:58.   PMCID: 4172963
Wei JT, Feng Z, Partin AW, Brown E, Thompson I, Sokoll L, Chan DW, Lotan Y, Kibel AS, Busby JE, Bidair M, Lin DW, Taneja SS, Viterbo R, Joon AY, Dahlgren J, Kagan J, Srivastava S, Sanda MG. Can urinary PCA3 supplement PSA in the early detection of prostate cancer?. J Clin Oncol. 2014 Dec 20;32(36):4066-72.   PMCID: Pmc4265117
Tchou J, Wang LC, Selven B, Zhang H, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Mesothelin, a novel immunotherapy target for triple negative breast cancer. Breast Cancer Res Treat. 2012 Jun;133(2):799-804.
Robinson MK, Hodge KM, Horak E, Sundberg AL, Russeva M, Shaller CC, von Mehren M, Shchaveleva I, Simmons HH, Marks JD, Adams GP. Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro. Br J Cancer. 2008 Nov 04;99(9):1415-25.   PMCID: PMC2576487
Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Molecular Cancer Therapeutics. 2005 Mar;4(3):351-60.
Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 2001 Jun 15;61(12):4750-5.
Adams GP, Weiner LM. Radioimmunotherapy of solid tumors: from fairytale to reality. Cancer Biother Radiopharm. 2001 Feb;16(1):9-11.
McCall AM, Shahied L, Amoroso AR, Horak EM, Simmons HH, Nielson U, Adams GP, Schier R, Marks JD, Weiner LM. Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity. J Immunol. 2001 May 15;166(10):6112-7.
Weiner LM. Bispecific antibodies in cancer therapy. Cancer journal (Sudbury, Mass). 2000 May;6 Suppl 3:S265-71.
Link BK, Weiner GJ. Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cells. Blood. 1993 Jun 15;81(12):3343-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Neoplasm Antigens

Neoplasm Antigens immunology metabolism Male Female Neoplasms methods Monoclonal Antibodies erbB-2 Receptor pathology Mice Human Immunotherapy T-Lymphocytes therapeutic use Tumor Cell Line therapy Kinetics genetics Bispecific Antibodies Antineoplastic Agents Adult Aged pharmacokinetics blood Middle Aged Tumor Biomarkers US Gov't Support-PHS Antitumor Drug Screening Assays Carbonic Anhydrases Prostatic Neoplasms Cell Proliferation Immunoglobulin Fragments analysis Histocompatibility Antigens Class II Flow Cytometry chemistry antagonists & inhibitors Histocompatibility Antigens Class I Treatment Outcome chemical synthesis drug effects Animal Antibody Affinity Breast Neoplasms Non-US Gov't Support adverse effects Antibody-Dependent Cell Cytotoxicity Tissue Distribution Indoles Cultured Tumor Cells Cohort Studies alpha Subunit Hypoxia-Inducible Factor 1 GPI-Linked Proteins erbB-3 Receptor Inbred ICR Mice Xenograft Model Antitumor Assays cancer Ovarian Neoplasms pd [Pharmacology] CCR5 Receptors immunotherapy Biological) 0 (Tumor Markers DNA interaction Von Hippel-Lindau Tumor Suppressor Protein Keratins tumor evolution 56-45-1 (Serine) SCID Mice Circulating Neoplastic Cells C-Type Lectins Carcinoembryonic Antigen CellSearch Immunoglobulin Fc Fragments radiotherapy Transfection Estrogen Receptors CTC cytometry Lymphoma X-Ray Computed Tomography Molecular Structure Dipeptides Fluorescence Microscopy Rabbits diagnosis Serine Complementary DNA Immunologic Adjuvants Mutation Angiogenesis Inhibitors Intracellular Fluid urine Inbred Strains Mice Immunologic Cytotoxicity Antigen-Antibody Reactions 0 (fibroblast-activating factor) physiology Drug Dose-Response Relationship Cell Adhesion Molecules Radioimmunotherapy Dimerization Vascular Endothelial Growth Factor A Age Factors Biopsy Western Blotting Calcium Signaling CD4-Positive T-Lymphocytes EC 3-4-14 (Dipeptidyl Peptidases) pharmacology Mhc-ii Precursor B-Cell Lymphoblastic Leukemia-Lymphoma toxicity Fibroblasts diagnostic use Anticancer therapy Molecular Models Non-US Gov't Research Support Thiosemicarbazones Pancreatitis-Associated Proteins CD8-Positive T-Lymphocytes Cell Line Early Detection of Cancer Catalytic Domain Binding Sites Molecular Weight Type II DNA Topoisomerases Serine Endopeptidases Immunohistochemistry Positron-Emission Tomography Antibody Binding Sites Hematopoietic Stem Cell Transplantation Cellular Immunity deficiency Circulating Tumor Cells Young Adult Topoisomerase inhibition Molecular Evolution IgG Receptors Radiometry Antibody Specificity Angiopoietin-2 Pyrroles Progesterone Receptors DNA-Binding Proteins Prospective Studies Complementary) 0 (DNA Structure-Activity Relationship cytology Neoplasm Antibodies Topoisomerase Inhibitors
Last updated on Wednesday, February 05, 2020